Cardinal Health news
The WiseView Research desk's stories that name Cardinal Health, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The CAH page →
- HeadlineCardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
- HeadlineCardinal Health (CAH) Laps the Stock Market: Here's Why
- HeadlineHere's Why Cardinal Health (CAH) is a Strong Growth Stock
- HeadlineAre Medical Stocks Lagging Cardinal Health (CAH) This Year?
- HeadlineShould Value Investors Buy Cardinal Health (CAH) Stock?
- HeadlineReasons to Retain Cardinal Health Stock in Your Portfolio for Now
- HeadlineCardinal Health (CAH) Outperforms Broader Market: What You Need to Know
- HeadlineCardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health
- HeadlineCardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5
- HeadlineCardinal Health: I'm Still Buying After Checking The Numbers
- CongressMarjorie Taylor Greene bought $1,001 - $15,000 of CAH
- CongressRo Khanna sold $1,001 - $15,000 of CAH
- CongressMarjorie Taylor Greene bought $1,001 - $15,000 of CAH
- CongressRob Bresnahan bought $1,001 - $15,000 of CAH
- CongressMarjorie Taylor Greene bought $1,001 - $15,000 of CAH
- CongressMarjorie Taylor Greene bought $1,001 - $15,000 of CAH
- CongressMarjorie Taylor Greene bought $1,001 - $15,000 of CAH
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.